Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tsuruo

Showing results (531-540 of 545) with videos related to

Pageof 55
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 1999
[Early detection and prevention of cancers in various therapeutic areas. Discussion]H Akaza, T Tsuruo, T Tsukamoto, et al.
British Journal of Cancer|December 22, 1999
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522S Tomozawa, H Nagawa, N Tsuno, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) geneF Narasaki, M Oka, M Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]H Akaza, K Aiba, S Isonishi, et al.
Japanese Journal of Cancer Research : Gann|November 7, 1999
A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumorsY Nihei, Y Suga, Y Morinaga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein moleculeP van der Valk, C K van Kalken, H Ketelaars, et al.
Biochemical Pharmacology|July 15, 1985
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionT C Hamilton, M A Winker, K G Louie, et al.
Biochemical Pharmacology|February 1, 1986
Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell linesK G Louie, T C Hamilton, M A Winker, et al.
Journal of the National Cancer Institute|May 4, 1994
MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell linesJ G Park, S K Lee, I G Hong, et al.
Cancer Research|August 27, 1999
Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panelT Yamori, A Matsunaga, S Sato, et al.
Pageof 55

Showing results (531-540 of 545) with videos related to

Sort By:
Pageof 55
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 30, 1999
[Early detection and prevention of cancers in various therapeutic areas. Discussion]H Akaza, T Tsuruo, T Tsukamoto, et al.
British Journal of Cancer|December 22, 1999
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522S Tomozawa, H Nagawa, N Tsuno, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) geneF Narasaki, M Oka, M Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]H Akaza, K Aiba, S Isonishi, et al.
Japanese Journal of Cancer Research : Gann|November 7, 1999
A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumorsY Nihei, Y Suga, Y Morinaga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein moleculeP van der Valk, C K van Kalken, H Ketelaars, et al.
Biochemical Pharmacology|July 15, 1985
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionT C Hamilton, M A Winker, K G Louie, et al.
Biochemical Pharmacology|February 1, 1986
Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell linesK G Louie, T C Hamilton, M A Winker, et al.
Journal of the National Cancer Institute|May 4, 1994
MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell linesJ G Park, S K Lee, I G Hong, et al.
Cancer Research|August 27, 1999
Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panelT Yamori, A Matsunaga, S Sato, et al.
Pageof 55